Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030191626485762 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | PLOS ONE |
| description | |
| discipline_display | Engineering & Technology |
| discipline_facet | Engineering & Technology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:10295 |
| institution | FRELIP |
| journal_source_facet | PLOS ONE |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study Cybersecurity, Cryptography and Privacy Computer Science & IT Engineering & Technology |
| sub_discipline_display | Computer Science & IT |
| sub_discipline_facet | Computer Science & IT |
| subject_display | Cybersecurity, Cryptography and Privacy Computer Science & IT Engineering & Technology Cybersecurity, Cryptography and Privacy Computer Science & IT Engineering & Technology |
| subject_facet | Cybersecurity, Cryptography and Privacy Computer Science & IT Engineering & Technology |
| title | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_auth | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_full | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_fullStr | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_full_unstemmed | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_short | Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study |
| title_sort | mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-ss-a antibody-positive rheumatoid arthritis: the answer cohort study |
| topic | Cybersecurity, Cryptography and Privacy Computer Science & IT Engineering & Technology |
| url | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344747 |